MedPath

THE SEARLE COMPANY LIMITED

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

PHILIPPINES:15

Drug Approvals

Jentin

Approval Date
Jul 14, 2025
PHILIPPINES

Calan

Approval Date
Jul 14, 2025
PHILIPPINES

Ventek

Approval Date
Jul 14, 2025
PHILIPPINES

SELANZ SR

Approval Date
Jul 14, 2025
PHILIPPINES

Xaroban

Approval Date
Jul 14, 2025
PHILIPPINES

Calan Sr

Approval Date
Jul 14, 2025
PHILIPPINES

Defnac

Approval Date
Jul 14, 2025
PHILIPPINES

Serlev

Approval Date
Jul 14, 2025
PHILIPPINES

Abrin

Approval Date
Jul 14, 2025
PHILIPPINES

Jentin

Approval Date
Jul 14, 2025
PHILIPPINES
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

Searle Secures Pakistani Regulatory Approval for Denosumab Biosimilar Injections

The Searle Company Limited has obtained registration from Pakistan's Drug Regulatory Authority for Denosumab biosimilar injections in 60mg and 120mg doses.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.